| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-455 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-75 |
| filingDate |
2002-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2005-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f88c93f2d045d1d995c20263e5112509
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f71327aa5526926d601a3101e0bc5e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_413d63e8c64dce853befdf279b21c262
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c83ec19ad8f450f16ce0c26ee850010a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92a74618fbf27022391b982ece95c239
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34e0cceeb6772e7a04bbcd17b6940aca |
| publicationDate |
2005-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2002250876-B2 |
| titleOfInvention |
Use of NK-1 receptor antagonists against benign prostatic hyperplasia |
| priorityDate |
2001-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |